Estats Units - anglès - NLM (National Library of Medicine)

physicians total care, inc. - phenol (unii: 339ncg44tv) (phenol - unii:339ncg44tv) - phenol 15 mg in 1 ml - first aid antiseptic

Estats Units - anglès - NLM (National Library of Medicine)

tagi pharma inc. - nivatopic plus is indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including atopic dermatitis, allergic contact dermatitis and radiation dermatitis. nivatopic plus also helps to relieve dry, waxy skin by maintaining a moist wound & skin environment, which is beneficial to the healing process. nivatopic plus is contraindicated in persons with a known hypersensitivity to any of the components of the formulation.

Estats Units - anglès - NLM (National Library of Medicine)

trigen laboratories, llc - avo creamtm topical emulsion is indicated for use in: - full thickness wounds, pressure sores, dermal ulcers including lower leg ulcers - superficial wounds - 1st and 2nd degree burns, including sunburns - dermal donor and graft site management - radiation dermatitis - minor abrasions avo creamtm topical emulsion is contraindicated for use on bleeding wounds, skin rashes related to food or medicine allergies, and when an allergy to one of the ingredients is known. avo creamtm topical emulsion is for topical use only as directed by a healthcare professional. wounds, abrasions, full thickness wounds, dermal graft site management and donor site management. - wash the affected area(s) with saline, clean water, or a suitable wound cleanser. - apply avo creamtm topical emulsion on and around the affected area(s) in thick layers 1/4 to 1/2 inch thick. - if applying gauze dressing, moisten the dressing lightly before application. - reapply avo creamtm topical emulsion as described above every 24 to 48 hours or as

Estats Units - anglès - myHealthbox

ecolab -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - rubella virus, quantity: 1000 ccid50; mumps virus, quantity: 5000 ccid50; measles virus, quantity: 1000 ccid50 - diluent, not applicable - excipient ingredients: water for injections - priorix is indicated for active immunisation against measles, mumps and rubella from 12 months of age.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - mumps virus, quantity: 5000 ccid50; measles virus, quantity: 1000 ccid50; rubella virus, quantity: 1000 ccid50 - injection, powder for - excipient ingredients: lactose; sorbitol; mannitol; threonine; serine; proline; glycine; alanine; valine; methionine; isoleucine; leucine; tyrosine; tryptophan; lysine hydrochloride; histidine; arginine; phenylalanine - priorix is indicated for active immunisation against measles, mumps and rubella from 12 months of age.

Estats Units - anglès - NLM (National Library of Medicine)

pedinol pharmacal, inc. - phenol (unii: 339ncg44tv) (phenol - unii:339ncg44tv) - first aid antiseptic

Estats Units - anglès - NLM (National Library of Medicine)

onpace pharma, llc - under the supervision of a healthcare professional, atopaderm cream is indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including atopic dermatitis, allergic contact dermatitis and radiation dermatitis. atopaderm cream also helps to relieve dry, waxy skin by maintaining a moist wound and skin environment, which is beneficial to the healing process. atopaderm cream is contraindicated in persons with a known hypersensitivity to any of the components of the formulation. dispense atopaderm cream into palm of hand and apply to affected area 3 times per day, or as directed by a physician. massage gently into the skin until completely absorbed. if the skin is broken, cover with appropriate dressing. atopaderm cream is non-sterile.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - ethanol, quantity: 70 % v/v; chlorhexidine gluconate, quantity: 2 % w/v - solution - excipient ingredients: basic fuchsin; purified water; glacial acetic acid; sodium hydroxide - tinted antiseptic applied to patient?s skin prior to invasive medical procedures. reduces bacteria that can cause skin infection and may also be used to maintain vascular access sites.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - ethanol, quantity: 70 % v/v; chlorhexidine gluconate, quantity: 2 % w/v - solution - excipient ingredients: glacial acetic acid; purified water; sodium hydroxide; basic fuchsin - tinted antiseptic applied to patient?s skin prior to invasive medical procedures. reduces bacteria that can cause skin infection and may also be used to maintain vascular access sites.